These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467 [TBL] [Abstract][Full Text] [Related]
3. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of bovine CD97: an EGF-TM7 molecule expressed as isoforms. Eichler W; Stieler JT; Vogel B; Wobus M; Aust G Mol Immunol; 2004 Jul; 41(8):751-8. PubMed ID: 15234554 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477 [TBL] [Abstract][Full Text] [Related]
6. Expression characteristics of the human CD97 antigen. Eichler W; Hamann J; Aust G Tissue Antigens; 1997 Nov; 50(5):429-38. PubMed ID: 9389316 [TBL] [Abstract][Full Text] [Related]
7. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814 [TBL] [Abstract][Full Text] [Related]
8. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells. Boulday G; Hamann J; Soulillou JP; Charreau B Transplantation; 2002 Feb; 73(3):429-36. PubMed ID: 11884941 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD97 and CD55 in human medullary thyroid carcinomas. Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104 [TBL] [Abstract][Full Text] [Related]
10. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55. Karpus ON; Veninga H; Hoek RM; Flierman D; van Buul JD; Vandenakker CC; vanBavel E; Medof ME; van Lier RA; Reedquist KA; Hamann J J Immunol; 2013 Apr; 190(7):3740-8. PubMed ID: 23447688 [TBL] [Abstract][Full Text] [Related]
11. CD97: a dedifferentiation marker in human thyroid carcinomas. Aust G; Eichler W; Laue S; Lehmann I; Heldin NE; Lotz O; Scherbaum WA; Dralle H; Hoang-Vu C Cancer Res; 1997 May; 57(9):1798-806. PubMed ID: 9135025 [TBL] [Abstract][Full Text] [Related]
12. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. Baetu TM; Kwon H; Sharma S; Grandvaux N; Hiscott J J Immunol; 2001 Sep; 167(6):3164-73. PubMed ID: 11544302 [TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of mouse CD97. Hamann J; van Zeventer C; Bijl A; Molenaar C; Tesselaar K; van Lier RA Int Immunol; 2000 Apr; 12(4):439-48. PubMed ID: 10744645 [TBL] [Abstract][Full Text] [Related]
14. Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells. Chun EM; Park YJ; Kang HS; Cho HM; Jun DY; Kim YH J Leukoc Biol; 2001 Apr; 69(4):645-50. PubMed ID: 11310852 [TBL] [Abstract][Full Text] [Related]
15. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006 [TBL] [Abstract][Full Text] [Related]
16. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878 [TBL] [Abstract][Full Text] [Related]
17. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Wobus M; Vogel B; Schmücking E; Hamann J; Aust G Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373 [TBL] [Abstract][Full Text] [Related]
18. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). Hamann J; Vogel B; van Schijndel GM; van Lier RA J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337 [TBL] [Abstract][Full Text] [Related]
19. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446 [TBL] [Abstract][Full Text] [Related]
20. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]